AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on Monday, the latest big investment by a pharmaceutical company reacting to ...
Original Image Link
Source:www.msn.com
Original Image Link
Source:www.msn.com
Posted: 2025-07-21 02:31:44